Hyperliquid Strategies Inc
PURR
NASDAQ
Biotechnology
$6.68
USD
-0.14 (-2.05%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.37B
Volume 5.4M
Price Target
$9.75 – $18.40
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $18.40 and a min estimate of $9.75.
Past 2Y
1Y Forecast
Price Targets
Average Target
$14.07
+$5.1 vs prior
Implied Upside
+110.6%
+75.9% vs prior
Analyst Covering
2
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Gareth Gacetta | Cantor Fitzgerald | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
James McIlree | Chardan Capital | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
ORIC
Oric Pharmaceuticals Inc
$13.87
▲ +1.1%
INBX
Inhibrx Biosciences Inc
$88.37
▼ -8.9%
CGEM
Cullinan Therapeutics Inc
$20.34
▲ +3.6%
NVAX
Novavax Inc
$8.05
▼ -1.1%
AKTS
Aktis Oncology Inc
$24.93
▲ +4.8%
AVBP
ArriVent BioPharma Inc
$29.51
▼ -1.6%
MGTX
MeiraGTx Holdings PLC
$13.52
▲ +6.7%
REPL
Replimune Group Inc
$14.97
▼ -1.4%
GLUE
Monte Rosa Therapeutics Inc
$15.50
▼ -2.1%